Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Return on Sales (2016 - 2025)

Nephros has reported Return on Sales over the past 16 years, most recently at 0.01% for Q4 2025.

  • Quarterly results put Return on Sales at 0.01% for Q4 2025, down 8.0% from a year ago — trailing twelve months through Dec 2025 was 0.06% (up 6.0% YoY), and the annual figure for FY2025 was 0.06%, up 6.0%.
  • Return on Sales for Q4 2025 was 0.01% at Nephros, down from 0.07% in the prior quarter.
  • Over the last five years, Return on Sales for NEPH hit a ceiling of 0.12% in Q1 2025 and a floor of 0.79% in Q3 2022.
  • Median Return on Sales over the past 5 years was 0.08% (2024), compared with a mean of 0.12%.
  • Biggest five-year swings in Return on Sales: tumbled -65bps in 2022 and later skyrocketed 74bps in 2023.
  • Nephros' Return on Sales stood at 0.12% in 2021, then soared by 57bps to 0.05% in 2022, then crashed by -279bps to 0.19% in 2023, then soared by 149bps to 0.09% in 2024, then plummeted by -86bps to 0.01% in 2025.
  • The last three reported values for Return on Sales were 0.01% (Q4 2025), 0.07% (Q3 2025), and 0.05% (Q2 2025) per Business Quant data.